There is a woody vine that grows in the understory of the Belizean rainforest, thin-stemmed and unremarkable, with leaves that smell faintly green when you crush them. Q'eqchi' Maya healers in Toledo District have brewed it for generations to treat susto, the fright illness their ancestors understood as a kind of soul loss. What makes this vine different from the hundreds of other plants in the same forest is what happened once researchers asked the healers what it was for: its active compound now sits inside an anti-anxiety product sold in the United States.
That is how Belize medicinal plants stopped being folklore and became a pharmacology story, and why a land buyer in Cayo should care which vines grow behind the building site.
What Susto Is, and Why Healers Reached for a Vine
Susto translates literally as "fright." Across Latin America it is a recognised culture-bound syndrome: a person suffers a shock or a near miss and afterwards cannot settle. They worry, sleep badly, lose their appetite, go listless. A Western clinician would write down generalised anxiety and reach for a prescription pad. A Q'eqchi' healer reaches for plants, prayer, and a ceremony.
The vine belongs to the genus Souroubea, in the family Marcgraviaceae, a group of neotropical lianas and shrubs nobody had screened for drug research. That was the appeal: an untouched branch of the plant kingdom attached to an oral tradition that specified exactly what it did.
Two species matter locally, Souroubea sympetala and Souroubea gilgii. Healers described a leaf decoction for the effects of what they called witchcraft, which in practice meant a patient presenting with anxiety after a fright. The same leaves went on bay-sore, a skin condition now identified as cutaneous leishmaniasis, the ulcerating parasite infection carried by sandflies in this part of Central America.
The Study That Let the Healers Set the Agenda
What separates this research from the usual bioprospecting story is who directed it. Working with Q'eqchi' healers and the Belize Indigenous Training Institute, a team from Canadian and US universities tested the plants the healers ranked as important, not the ones the researchers found interesting. Early work confirmed that preparations used against susto reduced anxiety behaviour in rodents. The 2014 paper that followed isolated the active principle: betulinic acid, a pentacyclic triterpene, effective in the standard elevated plus maze test at 0.5 mg per kilogram of body weight, alongside alpha and beta amyrin, lupeol and ursolic acid.
The mechanism is well understood. The extract acts as an agonist at the benzodiazepine binding site of the GABA-A receptor, the same receptor diazepam uses. That makes the vine something more than a mild tea with a nice story: it hits the pharmacological target the whole anti-anxiety drug class is built on, without the muscle-relaxation effect or withdrawal seen after prolonged benzodiazepine use in animals.
From a Village Remedy to a Product on US Shelves
Extraction came next. A Belize-collected extract made with supercritical carbon dioxide was compared against four solvent methods, then tested in rats. At 75 mg per kilogram, the treated animals spent about 50 percent more time in the open arms of the maze and cut their time in the closed arms by 42 percent, comparable to diazepam at 5 mg per kilogram.
The commercial path ran through veterinary medicine, not human medicine, and that was the smart route. Researchers blended Souroubea vine with American sycamore bark, Platanus occidentalis, at roughly 55:45 to raise betulinic acid content and cut cost per dose. The result is a chewable tablet marketed in the US as Zentrol, for dogs with noise aversion. A blinded, placebo-controlled study of 60 beagles exposed to recorded thunder found the recommended dose reduced inactivity and increased activity compared with placebo, with cortisol dropping in a dose-dependent pattern. The published efficacy study also reported the active triterpenes stayed stable in the tablet for 30 months, the unglamorous detail that separates a supplement from a manufacturing problem.
What the Human Trial Actually Measured
Human work exists, but it has to be described honestly. A registered trial, NCT03904511, gave healthy volunteers 190 mg of a Souroubea-Platanus preparation once daily for 14 days. The primary objective was safety and tolerability, not proving it treats anxiety. The secondary objective was whether the animal findings translated, measured through salivary cortisol and self-reported anxiety. Anyone claiming the vine is a proven human anxiolytic is ahead of the data. What the trial does show is that the knowledge travelled intact from village to clinic, which is rare. Most ethnobotanical leads die in a freezer somewhere.
169 Species, and a Garden Built to Keep Them
Souroubea is the headline, not the whole book. A survey conducted with nine Q'eqchi' healers from five villages documented 169 medicinal species across 67 plant families. The largest treatment categories were infections at 145 species, digestive complaints at 88, and nervous system conditions at 57. Half the plants came from secondary forest and 31 percent from primary forest, and the healers were explicit that undisturbed forest produced the stronger medicine.
Because those plants were getting harder to find near the villages, the healers built their own supply: the Itzamma Garden, a 50-acre site near Indian Creek where they transplanted 102 medicinal species. Belize also requires an access and benefit-sharing agreement before anyone collects plant material for drug development, so a foreign company cannot walk into Toledo District, take the vine, and leave. Whether those agreements pay healers fairly is a live argument, and it should be.
Reading the Same Forest on Your Own Land
Own jungle in Cayo and you own a piece of this pharmacopeia. The limestone ridges above the Belize River valley carry gumbo limbo, the tree with red peeling bark that looks like a sunburned tourist and works as a wash for rashes and insect bites. Allspice grows wild, and crushed leaves smell like clove, cinnamon and nutmeg at once. Copal trees bleed a resin the Maya burned in caves and Belizean bush doctors still use on wounds.
Learning to identify them changes how a parcel feels. A ridge that looks like scrub turns out to be a list of species with documented activity, growing on ground nobody ever cleared. It is the same reason a cave discovered by a farmer following his dog can turn a piece of land into a story worth telling.
Two warnings, and they are not decorative. The chechem tree, Metopium brownei, grows all over Cayo and its sap causes blistering rashes far worse than poison ivy, which is why a machete and short sleeves do not mix well here. And do not dose yourself from a plant list: the vine that treats susto acts on the same receptor as a prescription sedative, and dose matters.
Walk with someone who knows the plants. The medicinal trail above the Macal River at Chaa Creek, and the Maya villages around San Antonio, are where the knowledge still lives in people rather than search engines. Belize medicinal plants are not a curiosity from the past. One of them is in a bottle on a shelf in Florida, and the rest are still out there, rooted in limestone.
90 acres in Cayo with intact forest and its own cave
Uncleared jungle on limestone ridges means the plants in this article are growing here already, along with a Maya cave nobody had to rediscover. Walk the land and you are walking through a working pharmacy.
View the property →